The Hyderabad-based Nandan Biomatrix Ltd (NBL), an integrated natural solutions provider with focus on nutraceuticals, is planning to roll out Bio-Rhythm, an aphrodisiacs product, throughout India by the end of the year, it is learnt.

According to Nandan Biomatrix, it is looking forward to launch Bio-Rhythm, which has recently launched in the twin cities of Hyderabad and Secunderabad, throughout Andhra Pradesh and all Southern states in another two to three months. The company, which expects Rs 2 crore for the product from the twin cities, is targeting Rs 5 crore in the current financial year. The company stated that it is hopeful to generate the targeted Rs 5 crore with rolling out it across the country.

Speaking to Pharmabiz, C S Jadhav, director of marketing, Nandan Biomatrix, said, "We are getting good response for Bio-Rhythm from the twin cities. Now we are in the process to roll out Bio-Rhythm throughout Andhra Pradesh and in all four Southern states in the next two to three months." It is learnt that the company is targeting retailers for the promotion of the over-the-count product.

It is also learnt that company is looking forward to roll out the product in overseas markets such as Malaysia, Thailand, Myanmar, Hungary and Canada. It has also finalised marketing deals with the marketing agencies in these countries. It is now in the process of filing the dossiers and samples in these countries for marketing approval. Sources said that its next focus is Gulf Cooperation Council (GCC) countries. It is learnt that currently the company is in discussions with a few marketing agencies to market the product in the GCC countries. Nandan Biomatrix is also considering launching of Bio-Rhythm in the US and is in discussions with a few companies for the same.

Nandan Biomatrix is also looking forward to launch eight more products, including two health drinks and one aphrodisiac product for women, under the nutraceuticals segment. The health drink is a mix of aloe vera (aloe barbadensis miller) and stevia (stevia rebaudiana). The company, with growth rate of 30 to 40 per cent, is hoping to double its turnover of Rs 35 crore from the nutraceutical arena in the current financial year.